Melox Capsule (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to up to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg per day depending on response to treatment. Do not administer more than 15 mg of this medicine per day. Take it with water or another beverage during a meal. ○ In older adults or patients at increased risk of adverse reactions, treatment is usually initiated at a dose of 7.5 mg per day. ○ Patients with severe renal impairment receiving hemodialysis should not be given more than 7.5 mg per day.

This medication should be discussed with a doctor or pharmacist if taken by someone who regularly consumes more than three drinks per day as it may significantly increase the risk of gastrointestinal bleeding. This medication can increase the risk of cardiovascular disease, potentially leading to serious cardiovascular issues such as myocardial infarction or stroke; therefore, patients with cardiovascular diseases or risk factors should be cautious. This medication can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, or perforation, especially in elderly patients or those with a history of gastrointestinal disease, so it should be used with caution. This medication has the potential to cause serious skin adverse reactions and life-threatening hypersensitivity reactions; if symptoms such as skin rash or mucosal damage occur, it should be discontinued immediately. This medication can cause kidney-related side effects such as interstitial nephritis or impaired kidney function; patients with weak kidney function should be cautious. Liver dysfunction may occur, so if liver function test results are abnormal or if symptoms persist, this medication should be discontinued. This medication may reduce fertility; thus, women planning to become pregnant or those who may become pregnant should avoid taking it. This medication should not be administered to patients with certain allergic histories, gastrointestinal bleeding, severe liver impairment, severe kidney impairment, heart failure, hypertension, or inflammatory bowel disease. Elderly patients, those with a history of gastrointestinal diseases, and individuals at risk for cardiovascular diseases should use this medication cautiously, and care may be needed when driving or operating machinery. Blood tests, liver function tests, and kidney function tests should be conducted regularly while taking this medication to detect adverse reactions early and respond appropriately. This medication may interact with other non-steroidal anti-inflammatory drugs, anticoagulants, lithium, methotrexate, etc., so a doctor should be consulted, and careful monitoring is necessary when used in conjunction. Pregnant or breastfeeding women should not take this medication, especially in late pregnancy, as it may cause serious side effects in the fetus and newborn. This medication should be prescribed cautiously to elderly patients, and it is safest to use the minimum dose for the shortest duration possible. In case of overdose, gastric lavage and supportive therapy are required, and since no specific antidote exists, immediate medical attention should be sought. This medication should be stored out of reach of children, kept in the original container, and not transferred to other containers.

• Gastrointestinal bleeding
• cardiovascular thromboembolic events
• myocardial infarction
• stroke
• bleeding from the stomach or intestines
• ulcers
• perforation
• exfoliative dermatitis
• mucous membrane syndrome
• toxic epidermal necrolysis

This medication should be stored in a tightly closed container that protects it from light and preferably kept at room temperature between 1 and 30 degrees Celsius. It should be used within 36 months from the date of manufacture to maintain its efficacy and safety.

Appearance

A hard capsule with green upper and lower parts filled with a light yellow content

Package unit

30 capsules/bottle, 300 capsules/bottle, 500 capsules/bottle